Physician

Jerald B. Feinland, MD

According to 2025 Medicare claims, Jerald Feinland, MD (NPI: 1114986460) practices family practice in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is VALLEY MEDICAL GROUP, P.C. (NPI: 1912924705; TIN: 042945394) and primary practice location at 01027-1046. Feinland is affiliated with the Pioneer Valley Accountable Care, LLC (ACO ID: A5040), Aledade 205 New England MSSP Enhanced (ACO ID: A5370), and Aledade 201 National MSSP (ACO ID: A5522), participating under the MSSP model.

Feinland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 713 traditional Medicare patients, billed 5,508 HCPCS/CPT codes, and received $159,005 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,421 prescription claims across 466 beneficiaries totaling $500,652 in drug costs, led by Trulicity (Dulaglutide). DME data shows 112 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $229,492 to $500,652. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,985 and ending at $25,783.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	615	3,764	$139,577
2016	595	4,131	$144,507
2017	734	4,929	$170,808
2018	757	4,555	$167,224
2019	907	5,592	$199,145
2020	861	4,880	$165,789
2021	891	5,296	$184,662
2022	854	5,121	$176,162
2023	842	5,474	$185,903
2024	713	5,508	$159,005

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	308	4,604	$229,492
2016	343	4,590	$264,658
2017	338	4,382	$304,137
2018	426	4,633	$363,344
2019	428	4,595	$376,265
2020	436	4,951	$417,425
2021	383	4,972	$422,750
2022	432	4,738	$487,322
2023	460	4,957	$559,960
2024	466	5,421	$500,652

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	35	145	$3,504
2016	34	157	$5,565
2017	21	133	$5,355
2018	38	101	$2,485
2019	18	120	$3,367
2020	34	172	$4,871
2021	14	85	$3,268
2022	18	88	$5,102
2023	13	79	$7,132
2024	13	112	$13,824

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	208	419	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	188	248	$54
80061	Blood test, lipids (cholesterol and triglycerides)	231	283	$13
36415	Insertion of needle into vein for collection of blood sample	381	784	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	235	373	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	38	1,848	$59,727
Xarelto	Rivaroxaban	36	3,180	$56,395
Eliquis	Apixaban	38	1,915	$37,257
Ozempic	Semaglutide	33	1,122	$34,022
Mounjaro	Tirzepatide	17	588	$21,056

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	33	$10,628
E1161	Manual adult size wheelchair, includes tilt in space	Y	N/R	12	$2,331
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	13	26	$338
E1028	Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for joystick, other control interface or positioning accessory	Y	N/R	17	$236
E0955	Wheelchair accessory, headrest, cushioned, any type, including fixed mounting hardware, each	Y	N/R	12	$177

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jerald B. Feinland, MD?

Tedicare shows public-source Medicare data for Jerald B. Feinland, MD (NPI 1114986460), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jerald B. Feinland, MD have ACO affiliation data?

Jerald B. Feinland, MD is shown with ACO affiliation data for Pioneer Valley Accountable Care, LLC (MSSP, ACO ID A5040), Aledade 205 New England MSSP Enhanced (MSSP, ACO ID A5370), and Aledade 201 National MSSP (MSSP, ACO ID A5522).

What billing organization is linked to Jerald B. Feinland, MD?

Jerald B. Feinland, MD is linked to VALLEY MEDICAL GROUP, P.C. (billing NPI 1912924705) in the available physician profile data.

Does Jerald B. Feinland, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.